Collegium Pharmaceutical, Inc. (COLL) Social Stream



Collegium Pharmaceutical, Inc. (COLL): $15.66

0.17 (+1.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Collegium Pharmaceutical Inc (COLL) Price Targets From Analysts

Use the tables below to see what analysts covering Collegium Pharmaceutical Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 8 $36 $8 $24.857 $19.73 25.99%
2021-11-28 8 $36 $8 $25.142 $19.73 27.43%
2022-01-11 6 $36 $8 $25.142 $19.73 27.43%
2022-01-21 6 $36 $8 $25 $19.73 26.71%
2022-02-15 7 $36 $8 $25.5 $19.73 29.24%
2022-02-25 7 $42 $8 $27 $19.73 36.85%

The Trend in the Analyst Price Target


Over the past 46 weeks, COLL's average price target has gone down $3.07.

Over the past 46 weeks, COLL's average upside potential has been 31.41%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 10 40 29 33.170 25.15 31.89%
2021-11-15 8 36 8 25.142 20.01 25.65%
2021-11-28 8 36 8 25.142 17.95 40.07%
2022-02-21 7 42 8 26.500 21.75 21.84%
2022-02-25 7 42 8 27.000 19.36 39.46%

COLL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 5 1 0 1 1 7

The Trend in the Broker Recommendations


Over the past 26 weeks, COLL's average broker recommendation rating improved by 0.29.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for COLL as an investment opportunity.

  • COLL has a lower variance in analysts' estimates than -563.59% of all US stocks.
  • In the context of stocks in the small market cap category, Collegium Pharmaceutical Inc's number of analysts covering the stock is higher than 600.51% of them.
  • In terms of how Collegium Pharmaceutical Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 102.77% of that group.
  • Collegium Pharmaceutical Inc's average analyst price target is greater than 284.48% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Collegium Pharmaceutical Inc are COGT, CNTB, and CNTA.

Make investment decisions regarding COLL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6264 seconds.